Trident Texofab Share Price
Sector: Apparel/Accessories
215.00 -3.20 (-1.47%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
210.10
Today’s High
218.50
52 Week Low
36.15
52 Week High
220
Key Metrics
- Market Cap (In Cr) 255.27
- Beta -1.52
- Div. Yield (%) 0
- P/B 6.7
- TTM P/E 70.2
- Peg Ratio 3.25
- Sector P/E 0
- D/E 0.01
- Open Price 211.5
- Prev Close 218.2
Trident Texofab Analysis
Price Analysis
-
1 Week0.76%
-
3 Months24.83%
-
6 Month34.9%
-
YTD29.73%
-
1 Year355.91%
Risk Meter
- 33% Low risk
- 33% Moderate risk
- 33% Balanced Risk
- 33% High risk
- 33% Extreme risk
Trident Texofab News
GM Breweries Q2 Earnings Live Updates: Net profit up 4.1%, shares fell by 3.5%
3 min read . 11 Oct 2022Trident Texofab Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2025
- Total Revenue
- 122.06
- Selling/ General/ Admin Expenses Total
- 2.87
- Depreciation/ Amortization
- 1.65
- Other Operating Expenses Total
- 7.9
- Total Operating Expense
- 118.23
- Operating Income
- 3.82
- Net Income Before Taxes
- 2.58
- Net Income
- 2.51
- Diluted Normalized EPS
- 2.09
- Period
- 2025
- Total Assets
- 100.58
- Total Liabilities
- 53.34
- Total Equity
- 47.24
- Tangible Book Valueper Share Common Eq
- 32.55
- Period
- 2025
- Cashfrom Operating Activities
- -16.35
- Cashfrom Investing Activities
- 1.48
- Cashfrom Financing Activities
- 18.03
- Net Changein Cash
- 3.16
- Period
- 2024
- Total Revenue
- 99.48
- Selling/ General/ Admin Expenses Total
- 2.69
- Depreciation/ Amortization
- 1.65
- Other Operating Expenses Total
- 6.8
- Total Operating Expense
- 94.63
- Operating Income
- 4.85
- Net Income Before Taxes
- 1.17
- Net Income
- 1.08
- Diluted Normalized EPS
- 0.79
- Period
- 2024
- Total Assets
- 81.9
- Total Liabilities
- 65.64
- Total Equity
- 16.26
- Tangible Book Valueper Share Common Eq
- 16.14
- Period
- 2024
- Cashfrom Operating Activities
- 2.71
- Cashfrom Investing Activities
- -0.57
- Cashfrom Financing Activities
- -2.05
- Net Changein Cash
- 0.09
- Period
- 2023
- Total Revenue
- 96.36
- Selling/ General/ Admin Expenses Total
- 2.77
- Depreciation/ Amortization
- 1.64
- Other Operating Expenses Total
- 6.89
- Total Operating Expense
- 91.82
- Operating Income
- 4.53
- Net Income Before Taxes
- 2.73
- Net Income
- 2.22
- Diluted Normalized EPS
- 2.31
- Period
- 2023
- Total Assets
- 77.31
- Total Liabilities
- 62.13
- Total Equity
- 15.18
- Tangible Book Valueper Share Common Eq
- 15.07
- Period
- 2023
- Cashfrom Operating Activities
- 5.85
- Cashfrom Investing Activities
- 0.37
- Cashfrom Financing Activities
- -6.2
- Net Changein Cash
- 0.02
- Period
- 2022
- Total Revenue
- 84.29
- Selling/ General/ Admin Expenses Total
- 2.4
- Depreciation/ Amortization
- 1.47
- Other Operating Expenses Total
- 4.85
- Total Operating Expense
- 80.79
- Operating Income
- 3.5
- Net Income Before Taxes
- 1.27
- Net Income
- 0.98
- Diluted Normalized EPS
- 0.94
- Period
- 2022
- Total Assets
- 70.99
- Total Liabilities
- 58.03
- Total Equity
- 12.96
- Tangible Book Valueper Share Common Eq
- 12.87
- Period
- 2022
- Cashfrom Operating Activities
- 1.39
- Cashfrom Investing Activities
- -4.38
- Cashfrom Financing Activities
- 2.99
- Net Changein Cash
- 0
- Period
- 2021
- Total Revenue
- 49.93
- Selling/ General/ Admin Expenses Total
- 1.96
- Depreciation/ Amortization
- 1.02
- Other Operating Expenses Total
- 3.03
- Total Operating Expense
- 48.02
- Operating Income
- 1.91
- Net Income Before Taxes
- 0.9
- Net Income
- 0.35
- Diluted Normalized EPS
- 0.32
- Period
- 2021
- Total Assets
- 67.77
- Total Liabilities
- 55.8
- Total Equity
- 11.98
- Tangible Book Valueper Share Common Eq
- 11.89
- Period
- 2021
- Cashfrom Operating Activities
- 1.96
- Cashfrom Investing Activities
- -10.19
- Cashfrom Financing Activities
- 8.19
- Net Changein Cash
- -0.05
- Period
- 2020
- Total Revenue
- 90.96
- Selling/ General/ Admin Expenses Total
- 2.46
- Depreciation/ Amortization
- 1.01
- Other Operating Expenses Total
- 4.9
- Total Operating Expense
- 87.11
- Operating Income
- 3.86
- Net Income Before Taxes
- 1.53
- Net Income
- 0.9
- Diluted Normalized EPS
- 0.94
- Period
- 2020
- Total Assets
- 55.68
- Total Liabilities
- 44.05
- Total Equity
- 11.62
- Tangible Book Valueper Share Common Eq
- 11.54
- Period
- 2020
- Cashfrom Operating Activities
- -2.85
- Cashfrom Investing Activities
- -2.41
- Cashfrom Financing Activities
- 4.95
- Net Changein Cash
- -0.31
- Period
- 2019
- Total Revenue
- 86.9
- Selling/ General/ Admin Expenses Total
- 1.93
- Depreciation/ Amortization
- 0.3
- Other Operating Expenses Total
- 3.06
- Total Operating Expense
- 84.81
- Operating Income
- 2.08
- Net Income Before Taxes
- 1.69
- Net Income
- 1.27
- Diluted Normalized EPS
- 1.33
- Period
- 2019
- Total Assets
- 47.04
- Total Liabilities
- 36.05
- Total Equity
- 11
- Tangible Book Valueper Share Common Eq
- 11.47
- Period
- 2019
- Cashfrom Operating Activities
- -2.75
- Cashfrom Investing Activities
- -6.61
- Cashfrom Financing Activities
- 9.59
- Net Changein Cash
- 0.22
- Period
- 2025-03-31
- Total Revenue
- 38.21
- Selling/ General/ Admin Expenses Total
- 0.81
- Depreciation/ Amortization
- 0.41
- Other Operating Expenses Total
- 3.19
- Total Operating Expense
- 37.31
- Operating Income
- 0.89
- Net Income Before Taxes
- 0.38
- Net Income
- 0.51
- Diluted Normalized EPS
- 0.47
- Period
- 2025-03-31
- Total Assets
- 100.58
- Total Liabilities
- 53.34
- Total Equity
- 47.24
- Tangible Book Valueper Share Common Eq
- 32.55
- Period
- 2025-03-31
- Cashfrom Operating Activities
- -16.35
- Cashfrom Investing Activities
- 1.48
- Cashfrom Financing Activities
- 18.03
- Net Changein Cash
- 3.16
- Period
- 2024-12-31
- Total Revenue
- 31.69
- Selling/ General/ Admin Expenses Total
- 0.64
- Depreciation/ Amortization
- 0.41
- Other Operating Expenses Total
- 1.91
- Total Operating Expense
- 29.73
- Operating Income
- 1.96
- Net Income Before Taxes
- 0.32
- Net Income
- 0.3
- Diluted Normalized EPS
- 0.16
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 26.45
- Selling/ General/ Admin Expenses Total
- 0.76
- Depreciation/ Amortization
- 0.41
- Other Operating Expenses Total
- 2.03
- Total Operating Expense
- 27.14
- Operating Income
- -0.69
- Net Income Before Taxes
- 0.95
- Net Income
- 1
- Diluted Normalized EPS
- 1
- Period
- 2024-09-30
- Total Assets
- 86.16
- Total Liabilities
- 68.2
- Total Equity
- 17.96
- Tangible Book Valueper Share Common Eq
- 17.83
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -3.48
- Cashfrom Investing Activities
- 4.74
- Cashfrom Financing Activities
- -1.25
- Net Changein Cash
- 0.01
- Period
- 2024-06-30
- Total Revenue
- 25.71
- Selling/ General/ Admin Expenses Total
- 0.66
- Depreciation/ Amortization
- 0.41
- Other Operating Expenses Total
- 1.32
- Total Operating Expense
- 24.6
- Operating Income
- 1.11
- Net Income Before Taxes
- 0.92
- Net Income
- 0.7
- Diluted Normalized EPS
- 0.69
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 30.17
- Selling/ General/ Admin Expenses Total
- 0.72
- Depreciation/ Amortization
- 0.41
- Other Operating Expenses Total
- 2.35
- Total Operating Expense
- 28.68
- Operating Income
- 1.5
- Net Income Before Taxes
- -0.14
- Net Income
- -0.1
- Diluted Normalized EPS
- -0.33
- Period
- 2024-03-31
- Total Assets
- 81.9
- Total Liabilities
- 65.64
- Total Equity
- 16.26
- Tangible Book Valueper Share Common Eq
- 16.14
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 2.71
- Cashfrom Investing Activities
- -0.57
- Cashfrom Financing Activities
- -2.05
- Net Changein Cash
- 0.09
- Period
- 2023-12-31
- Total Revenue
- 23.01
- Selling/ General/ Admin Expenses Total
- 0.66
- Depreciation/ Amortization
- 0.41
- Other Operating Expenses Total
- 1.39
- Total Operating Expense
- 21.52
- Operating Income
- 1.49
- Net Income Before Taxes
- 0.67
- Net Income
- 0.56
- Diluted Normalized EPS
- 0.55
- Period
- 2023-12-31
- Period
- 2023-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Trident Texofab Technical
Moving Average
SMA
- 5 Day216.56
- 10 Day215.28
- 20 Day212.34
- 50 Day202.5
- 100 Day186.93
- 300 Day147.47
Trident Texofab Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Vip Clothing
- 39.83
- -0.15
- -0.38
- 53.15
- 28
- 358.98
- Dcm Nouvelle
- 181.8
- 4.8
- 2.71
- 297.55
- 144.6
- 339.57
- Trident Texofab
- 215
- -3.2
- -1.47
- 220
- 36.15
- 255.27
- Maral Overseas
- 75.4
- 0.5
- 0.67
- 96.89
- 56
- 315.72
- Gillanders Arbuthnot And Co
- 140.65
- 2.45
- 1.77
- 150
- 81
- 300.18
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Vip Clothing
- 64.27
- 1.95
- -0.53
- -0.4
- Dcm Nouvelle
- 71.99
- 1.03
- 12.54
- 3.71
- Trident Texofab
- 104.4
- 6.7
- 8.33
- 1.58
- Maral Overseas
- -
- 2.83
- 4.69
- 0.62
- Gillanders Arbuthnot And Co
- 18.22
- 1.2
- -0.5
- -0.3
Trident Texofab Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 29-May-25
- Audited Results
- 03-Feb-25
- Quarterly Results
- 23-Oct-24
- Others
- 12-Oct-24
- Quarterly Results
- 18-Jul-24
- Quarterly Results
- 17-Jul-24
- Quarterly Results
- 25-May-24
- Audited Results
- 21-May-24
- Audited Results
- 14-Feb-24
- Quarterly Results
- 06-Nov-23
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 14-Jun-25
- 13-May-25
- POM
- 16-Nov-24
- 24-Oct-24
- EGM
- 27-Sept-24
- 21-Aug-24
- AGM
- 29-Sept-23
- 11-Aug-23
- AGM
- -
- 22-Aug-24
- AGM



